Purpose of this Study: This study examines the safety and effectiveness of the study drug, as compared to placebo, in adults with negative symptoms of schizophrenia. Negative symptoms include flat affect, apathy, inability to feel pleasure, reduced social drive, loss of motivation, and lack of social interest.
Length of Study: One year, which is primarily outpatient but does include a 2-4 night inpatient period at both the beginning and end of the first 12 weeks.
Qualified Study Participants Will Receive:
- Study-related care and office visits at no cost
- Medication at no cost
- $75 compensation per outpatient visit; $100 compensation per inpatient visit
Am I Eligible for the Study?
- Aged 18 – 55 years old
- Primary diagnosis of schizophrenia for at least one year
- Currently experiencing negative symptoms
- Medically stable with a stable living residence
Note: These are not the only eligibility criteria for this clinical research study, and other criteria may exclude you.
Why Should You Participate? All new medicines are tested in clinical trials. You may also help others by advancing science, and you may gain access to a new treatment.
Interested in Participating? If you are interested in joining this study, please fill out the form below to provide your contact information, or call our office at (773) 989-8313 x 117 and leave a message on our screening line. A member of our staff will call you back and will conduct a short phone screen to determine if you should visit our office for further evaluation.